Announcements Trials
Browse Landscape

Status

Completed 151Recruiting 90Unknown 70Terminated 36Active not recruiting 35Withdrawn 19Not yet recruiting 18No longer available 3Enrolling by invitation 3Suspended 1Available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

CNS 7Tumor-Agnostic 5Other hematologic neoplasm 4Sarcoma 3Head & Neck 3Endocrine 3Thoracic 2Myeloid 2Gynecologic 2Genitourinary 2Gastrointestinal 2Breast 2Plasma cell 1NET 1Lymphoid 1Classical hematology 1

Conditions

Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Liposarcoma 1Insulinoma 1Hypoglycemia 1Hyperinsulinism 1Fibrosarcoma 1Adenoma, Islet Cell 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × OTHER × NET × Clear all
NCT07262970 2025-12-04

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Rezolute

Available
EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡